Biotechnology Industry News, Armand RoussoLatest Biotechnology News, Armand RoussoBiotechnology News, Armand Rousso
Biotechnology News by
Armand Rousso R&D Labs
Biotechnology Industry News, Armand RoussoLatest Biotechnology News, Armand RoussoBiotechnology News, Armand Rousso
 
 
Creating new and successful businesses with world-class people and technologies - that is one thought that drives Armand Rousso - the visionary entrepreneur. Armand Rousso has seized numerous opportunities to launch new and successful business ventures in the world of High-Technology.


Biotechnology News by Armand Rousso R&D Labs
Yahoo! News: Biotechnology News

Yahoo! News: Biotechnology News

Biotechnology News

10/11/2008 03:16 AM
Stem cell generation from ordinary cells now safe (Reuters)
Reuters - Japanese researchers who invented a way to make powerful stem cells out of ordinary cells say they have now found a safer way to do it.
10/10/2008 04:32 AM
Biogen discontinues experimental arthritis drug (Reuters)
Reuters - Biogen Idec Inc said on Thursday it will discontinue development of baminercept as a treatment for rheumatoid arthritis after the experimental drug failed to prove effective in a mid-stage trial.
10/09/2008 07:12 PM
Europeans reject animal cloning for food: survey (Reuters)
Reuters - Most Europeans have reservations about cloning animals for food, while 67 percent see cloning as justified if used to preserve rare animal species, a survey that could help forge EU policy in the area showed on Thursday.
10/09/2008 09:18 AM
Blood Cell Genes May Signal Heart Disease (HealthDay)
HealthDay - WEDNESDAY, Oct. 8 (HealthDay News) -- A test that measures the activity of genes in white blood cells might someday help doctors determine the proper treatment when someone complains of chest pain, researchers report.
10/08/2008 10:46 PM
Genetics: Scientists unravel two more strains of malaria parasite (AFP/USDA/File)

In this Dec.21, 2005 file picture a mother gently places her son in a basket, as she takes him to a  Medecins Sans Frontieres clinic, in Lankien, Southern Sudan after he contracted malaria. An international medical aid group says free malaria treatment for Africa's poorest is key to combatting a disease that kills nearly 1 million people a year. (AP Photo/Karel Prinsloo, File)AFP/USDA/File - Scientists on Wednesday said they had cracked the genetic codes of a major malaria parasite and a monkey parasite also suspected of spreading the disease, an achievement adding to the sequencing six years ago of Plasmodium falciparum, the greatest malarial threat.



10/08/2008 11:29 AM
University: Stem-cell study used falsified data (AP)

Ampoules containing a medium for stem cell storage are displayed at the UK Stem Cell Bank in north London, May 19, 2004. (Peter Macdiarmid/Reuters)AP - The University of Minnesota has concluded that falsified data were used in a 2001 article published by one of its researchers on adult stem cells. The school is asking that the article be retracted.



10/08/2008 09:18 AM
Genes Give Clues to Age-Linked Eye Trouble (HealthDay)
HealthDay - MONDAY, Oct. 6 (HealthDay News) -- Variants in the gene that helps produce vital proteins in the eye have been linked to age-related macular degeneration (AMD), a major source of blindness, a new report says.
10/07/2008 04:03 AM
Eli Lilly bids $6.5 billion for ImClone (Reuters)

A laboratory researcher in a file photo. (File/Reuters)Reuters - Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, outbidding Bristol-Myers Squibb Co and potentially bringing to a close one of the most colorful corporate sagas in biotech history.



10/06/2008 11:27 PM
Genes may explain racial disparities in asthma (Reuters)
Reuters - Asthma patients who are black tend to have more severe disease than asthma patients who are white, leading to more asthma control problems, higher rates of emergency department visits, and overall worse quality of life. These findings point to genetic differences that lead to poor responses to drug therapy as the source of these racial disparities.
10/06/2008 07:04 PM
US cancer specialist at centre of 6.5-bln-dlr takeover battle (AFP)

US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with biotech firm ImClone, which is also a target for rival Bristol-Myers Squibb (BMS).(ImClone)AFP - US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with biotech firm ImClone, which is also a target for rival Bristol-Myers Squibb (BMS).